Annals of Hematology

, Volume 87, Issue 9, pp 735–740

Frequencies of the haemochromatosis gene (HFE) variants C282Y, H63D and S65C in 6,020 ethnic Danish men

Original Article


The objective was to assess the frequencies of haemochromatosis (HFE) gene mutations or variants C282Y, H63D and S65C in ethnic Danes. This is a prospective epidemiologic population study. A cohort of 6,020 Danish men aged 30–50 years was screened for HFE C282Y (c845G→A), H63D (c187C→G) and S65C (c193A→T) gene variants, assessed on saliva or blood samples by restriction fragment length polymorphism (RFLP) analysis. The C282Y gene variant allele was present in 5.6%, H63D in 12.8% and S65C in 1.8% of the chromosomes. In the entire series, we observed 1.4% H63D/C282Y, 0.1% S65C/C282Y and 0.4% H63D/S65C compound heterozygotes. The C282Y allele frequency in Denmark is of similar order as reported in other Scandinavian countries: Iceland 5.1%, Faeroe Islands 6.6%, Norway 6.8% and Sweden 5.8%. Also, the H63D frequency in Denmark is close to the frequencies in other Scandinavian countries: Iceland 10.9%, Faeroe Islands 15.2%, Norway 11.4% and Sweden 12.1%.


Denmark Genotypes Hemochromatosis Mutations Prevalence Scandinavia 


  1. 1.
    Barton JC (2000) A brief history of hemochromatosis. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology, diagnosis and treatment. Cambridge University Press, Cambridge, UK, pp 3–7Google Scholar
  2. 2.
    Milman N (1991) Hereditary haemochromatosis in Denmark 1950–1985. Clinical, biochemical and histological features in 179 patients and 13 preclinical cases. Dan Med Bull 38:385–393 MedlinePubMedGoogle Scholar
  3. 3.
    Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408 Medline. DOI 10.1038/ng0896-399 PubMedCrossRefGoogle Scholar
  4. 4.
    Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW et al (1996) Haemochromatosis and HLA-H. Nat Genet 14:249–251 Medline. DOI 10.1038/ng1196-249 PubMedCrossRefGoogle Scholar
  5. 5.
    Koefoed P, Dalhoff K, Dissing J, Kramer I, Milman N, Pedersen P et al (2002) HFE mutations and hemochromatosis in Danish patients admitted for HFE genotyping. Scand J Clin Lab Invest 62:527–535 Medline. DOI 10.1080/003655102321004549 PubMedCrossRefGoogle Scholar
  6. 6.
    Wiggers P, Dalhøj J, Kiær H, Ring-Larsen H, Petersen PH, Blaabjerg O et al (1991) Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med 230:265–270 MedlinePubMedGoogle Scholar
  7. 7.
    Milman N, Pedersen P, Ovesen L, Melsen GV, Fenger K (2004) Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes. Ann Hematol 83:654–657 Medline. DOI 10.1007/s00277-004-0874-7 PubMedCrossRefGoogle Scholar
  8. 8.
    Milman N, Pedersen P, Steig T, Melsen GV (2003) Frequencies of the hereditary hemochromatosis allele in different populations. Comparison of previous phenotypic methods and novel genotypic methods. Int J Hematol 77:48–54 MedlinePubMedCrossRefGoogle Scholar
  9. 9.
    Milman N (2000) Inheritance of hemochromatosis: family studies. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology, diagnosis and treatment. Cambridge University Press, Cambridge, UK, pp 15–41Google Scholar
  10. 10.
    Worwood M (1998) Haemochromatosis. Clin Lab Haematol 20:65–75 Medline. DOI 10.1046/j.1365-2257.1998.00028.x PubMedCrossRefGoogle Scholar
  11. 11.
    Rudbeck L, Dissing J (1998) Rapid, simple alkaline extraction of human genomic DNA from whole blood, buccal epithelial cells, semen and forensic stains for PCR. Biotechniques 25:588–590 MedlinePubMedGoogle Scholar
  12. 12.
    Hoppe BL, Conti-Tronconi BM, Horton RM (1992) Gel-loading dyes compatible with PCR. Biotechniques 12:679–680 MedlinePubMedGoogle Scholar
  13. 13.
    Thorstensen K, Asberg A, Kvitland M, Svaasand E, Hveem K, Bjerve KS (2000) Detection of an unusual combination of mutations in the HFE gene for hemochromatosis. Genet Test 4:371–376 Medline. DOI 10.1089/109065700750065117 PubMedCrossRefGoogle Scholar
  14. 14.
    Lucotte G, Champenois T, Semonin O (2001) A rare case of a patient heterozygous for the hemochromatosis mutation C282Y and homozygous for H63D. Blood Cells Mol Dis 27:892–893 Medline. DOI 10.1006/bcmd.2001.0451 PubMedCrossRefGoogle Scholar
  15. 15.
    Best LG, Harris PE, Spriggs EL (2001) Hemochromatosis mutations C282Y and H63D in ‘cis’ phase. Clin Genet 60:68–72 Medline. DOI 10.1034/j.1399-0004.2001.600111.x PubMedCrossRefGoogle Scholar
  16. 16.
    Milman N, Pedersen P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 64:36–47 Medline. DOI 10.1034/j.1399-0004.2003.00083.x PubMedCrossRefGoogle Scholar
  17. 17.
    Milman N, Koefoed P, Pedersen P, Nielsen FC, Eiberg H (2003) Frequency of the HFE C282Y and H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods. Eur J Haematol 71:403–407 Medline. DOI 10.1046/j.0902-4441.2003.00156.x PubMedCrossRefGoogle Scholar
  18. 18.
    Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Norgaard-Pedersen B, Robson KJ (1999) A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 13:154–159 Medline. DOI 10.1002/(SICI)1098-1004(1999)13:2<154::AID-HUMU8>3.0.CO;2-E PubMedCrossRefGoogle Scholar
  19. 19.
    Steffensen R, Varming K, Jersild C (1998) Determination of gene frequencies for two common haemochromatosis mutations in the Danish population by a novel polymerase chain reaction with sequence-specific primers. Tissue Antigens 52:230–235 MedlinePubMedGoogle Scholar
  20. 20.
    Simonsen K, Dissing J, Rudbeck L, Schwartz M (1999) Rapid and simple determination of hereditary haemochromatosis mutations by multiplex PCR-SSCP: detection of a new polymorphic mutation. Ann Hum Genet 63:193–197 Medline. DOI 10.1046/j.1469-1809.1999.6330193.x PubMedCrossRefGoogle Scholar
  21. 21.
    Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, Larsen LE, Appleyard M, Frandsen M et al (2001) Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet 358:1405–1409 Medline. DOI 10.1016/S0140-6736(01)06526-6 PubMedCrossRefGoogle Scholar
  22. 22.
    Bathum L, Christiansen L, Nybo H, Ranberg KA, Gaist D, Jeune B et al (2001) Association of mutations in the hemochromatosis gene with shorter life expectancy. Arch Intern Med 161:2441–2444 Medline. DOI 10.1001/archinte.161.20.2441 PubMedCrossRefGoogle Scholar
  23. 23.
    Distante S, Berg JP, Lande K, Haug E, Bell H (2000) HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut 47:575–579 Medline. DOI 10.1136/gut.47.4.575 PubMedCrossRefGoogle Scholar
  24. 24.
    Undlien DE, Bell H, Heier HE, Akselsen HE, Thorsby E (1998) Genetic diagnostic test for hemochromatosis. Tidsskr Nor Laegeforen 118:238–240 MedlinePubMedGoogle Scholar
  25. 25.
    Beckman LE, Sjoberg K, Eriksson S, Beckman L (2001) Haemochromatosis gene mutations in Finns, Swedes and Swedish Saamis. Hum Hered 52:110–112 Medline. DOI 10.1159/000053362 PubMedCrossRefGoogle Scholar
  26. 26.
    Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT (1999) Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 100:1274–1279 MedlinePubMedGoogle Scholar
  27. 27.
    Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278 MedlinePubMedGoogle Scholar
  28. 28.
    Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K (2001) Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 80:737–744 Medline. DOI 10.1007/s002770100371 PubMedCrossRefGoogle Scholar
  29. 29.
    Milman N, Clausen J, Byg KE (1998) Iron status in 268 Danish women aged 18–30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol 77:13–19 Medline. DOI 10.1007/s002770050405 PubMedCrossRefGoogle Scholar
  30. 30.
    Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211–218 Medline. DOI 10.1016/S0140-6736(02)07447-0 PubMedCrossRefGoogle Scholar
  31. 31.
    Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718–724 Medline. DOI 10.1056/NEJM199909023411002 PubMedCrossRefGoogle Scholar
  32. 32.
    McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer-Strawn L (1999) Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 107:30–37 Medline. DOI 10.1016/S0002-9343(99)00163-1 PubMedCrossRefGoogle Scholar
  33. 33.
    Phatak PD, Ryan DH, Cappuccio J, Oakes D, Braggins C, Provenzano K et al (2002) Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Blood Cells Mol Dis 29:41–47 Medline. DOI 10.1006/bcmd.2002.0536 PubMedCrossRefGoogle Scholar
  34. 34.
    Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM et al (1998) The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43:830–836 MedlinePubMedCrossRefGoogle Scholar
  35. 35.
    Milman N, Graudal N, Nielsen LS, Mathiassen B, Tauris P, Lund B et al (1990) Family studies of hereditary hemochromatosis in Denmark and the Faroe Islands. Hum Genet 85:228–232 Medline. DOI 10.1007/BF00193201 PubMedCrossRefGoogle Scholar
  36. 36.
    Milman N, Steig T, Koefoed P, Pedersen P, Nielsen FC (2005) Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faeroe Islands. Ann Hematol 84:146–149 Medline. DOI 10.1007/s00277-004-0865-8 PubMedCrossRefGoogle Scholar
  37. 37.
    Distante S, Berg JP, Lande K, Haug E, Bell H (1999) High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand J Gastroenterol 34:529–534 Medline. DOI 10.1080/003655299750026290 PubMedCrossRefGoogle Scholar
  38. 38.
    Holmstrom P, Marmur J, Eggertsen G, Gafvels M, Stal P (2002) Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 51:723–730 Medline. DOI 10.1136/gut.51.5.723 PubMedCrossRefGoogle Scholar
  39. 39.
    Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, de Sousa M et al (1998) HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 243:203–208 Medline. DOI 10.1046/j.1365-2796.1998.00270.x PubMedCrossRefGoogle Scholar
  40. 40.
    Hannuksela J, Leppilampi M, Peuhkurinen K, Karkkainen S, Saastamoinen E, Helio T et al (2005) Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 7:103–108 Medline. DOI 10.1016/j.ejheart.2004.03.007 PubMedCrossRefGoogle Scholar
  41. 41.
    Halme L, Helio T, Makinen J, Hockerstedt K, Farkkila M, Piippo K et al (2001) HFE haemochromatosis gene mutations in liver transplant patients. Scand J Gastroenterol 36:881–885 MedlinePubMedGoogle Scholar
  42. 42.
    Syrjakoski K, Fredriksson H, Ikonen T, Kuukasjarvi T, Autio V, Matikainen MP et al (2006) Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients. Int J Cancer 118:518–520 Medline. DOI 10.1002/ijc.21331 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Palle Pedersen
    • 1
  • Gitte Vedel Melsen
    • 1
  • Nils Milman
    • 1
  1. 1.Department of Clinical BiochemistryNæstved HospitalNæstvedDenmark

Personalised recommendations